• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS XT CHEMISTRY PRODUCTS GLU-CA SLIDES; IN-VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS XT CHEMISTRY PRODUCTS GLU-CA SLIDES; IN-VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6844295
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/02/2021
Event Type  malfunction  
Event Description
The investigation determined that lower than expected calcium quality control results were obtained from non-vitros biorad multiqual unassayed chemistry control lot 56630 l3 control fluid using vitros chemistry products caxt slides on a vitros xt7600 integrated system.Biorad lot 56630 l3 results of 9.26, 8.55, 9.64, 8.70, 9.92, 7.89 and 9.37 mg/dl vs.The expected result of 12.5 mg/dl.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The results were obtained from a non-patient control fluid, there was no reported allegation of patient harm as a result of this event.This report is number two of seven mdr¿s for this event.Seven 3500a forms are being submitted for this event as seven devices were involved.This report corresponds to ortho clinical diagnostics inc (ortho) complaint number (b)(4).
 
Manufacturer Narrative
The investigation determined that lower than expected quality control results were obtained from non-vitros biorad multiqual unassayed chemistry control lot 56630 l3 control fluid using vitros chemistry products caxt slides on a vitros xt7600 integrated system.The investigation could not determine an assignable cause with the information provided.A review of historical quality control results indicated there was within-lab imprecision occurring within the timeframe of the event.Therefore, a performance issue with vitros caxt slide lot 7413-0008-4702 cannot be ruled out as contributing to the event.However, continual tracking and trending of complaints has not identified any signals that would point to a potential systemic issue with vitros caxt slide lot 7413-0008-4702.Improper sample storage was ruled out as a contributor to the event as the customer was following sample storage recommendations for open-vial stability of 14 days.However, improper fluid handling protocol could not be ruled out as contributing to the event.Acceptable vitros caxt results were obtained by retesting qc fluid from the same biorad qc vials and not from new vials.It is possible that the biorad controls were tested immediately after being removed from refrigerated storage and were not allowed to equilibrate to analyzer temperature prior to testing as recommended by ortho.Since retesting the same fluids resolved the issue, it is possible the fluid temperature had equilibrated to analyzer temperature prior to repeat testing, although this could not be confirmed.It is unlikely an instrument performance issue contributed to the event because lower than expected results were obtained on non-consecutive days within a 2.5 month time interval of quality control results that were reviewed.However, since no diagnostic within-run precision testing was performed to assess the performance of the vitros xt7600 integrated system was performed, an instrument related performance issue cannot be completely ruled out as contributing to the event.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS XT CHEMISTRY PRODUCTS GLU-CA SLIDES
Type of Device
IN-VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
MDR Report Key12536229
MDR Text Key283770199
Report Number1319809-2021-00142
Device Sequence Number1
Product Code CGA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial
Report Date 09/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/27/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/01/2022
Device Catalogue Number6844295
Device Lot Number7413-0008-4702
Was Device Available for Evaluation? Yes
Date Manufacturer Received08/30/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-